Skip to main content

Table 4 Association of cardiovascular comorbidities with the use of glucocorticoids

From: Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study

  Glucocorticoids  
Yes n*(%) No n*(%) PRˆ (IC95%) p
Cardiovascular Comorbidities Yes 322 (66.9) 388 (66.1) 0.921 (0.842–1.007) 0.070
No 207 (39.1) 199 (33.9) 1.154 (0.988–1.348)
Systemic Arterial Hypertension Yes 257 (48.6) 300 (51.1) 0.951 (0.845–1.070) 0.400
No 272 (51.4) 287 (48.9) 1.052 (0.935–1.182)
Dyslipidemia Yes 151 (28.5) 212 (36.1) 0.790 (0.665–0.939) 0.007
No 378 (71.5) 375 (63.9) 1.119 (1.031–1.213)
Diabetes Mellitus Yes 74 (14) 92 (15.7) 0.893 (0.673–1.184) 0.430
No 455 (86) 495 (84.3) 1.020 (0.971–1.071)
Congestive Heart Failure Yes 11 (2.1) 13 (2.2) 0.939 (0.424–2.078) 0.876
No 518 (97.9) 574 (97.8) 1.001 (0.984–1.019)
Cerebrovascular Disease Yes 12 (2.3) 12 (2) 1.110 (0.503–2.449) 0.797
No 517 (97.7) 575 (98) 0.998 (0.980–1.015)
Acute Myocardial Infarction Yes 8 (1.5) 9 (1.5) 0.986 (0.383–2.538) 0.977
No 521 (98.5) 578 (98.5) 1.000 (0.986–1.015)
Peripheral Vascular Disease Yes 4 (0.8) 4 (0.7) 1.110 (0.279–4.415) 1.000
No 525 (99.2) 583 (99.3) 0.999 (0.989–1.009)
  1. *Absolute frequencies; ˆ Prevalence Ratio Significance level